| 07:50 – 09:00 | Registration | |
| 09:00 – 09:10 | Opening Remarks | |
| Session 4: Pediatric Rheumatology | ||
| 09:10 – 10:00 | Testing for Autoinflammatory Conditions: How to Interpret the Results? | Leonardo Oliveira Mendonça |
| 10:00 – 10:50 | JAK Inhibitors in Juvenile Idiopathic Arthritis (JIA) – Update from Recent Clinical Trials | A.V. Ramanan |
| 10:50 – 11:10 | ADARRCTM Networking & Refreshment Break | |
| Session 5: Metabolic Bone | ||
| 11:10 – 12:00 | Update on Treatment of Osteoporosis | Alexandra Papaioannou |
| 12:00 – 12:50 | Efficacy of Burosumab in Treating Adults with X-Linked Hypophosphataemia (XLH): Evidence from the Trials and Real-Life Experience | Judith Bubbear |
| 12:50 – 14:20 | Lunch Break | |
| Session 6: Combined Rounds II | ||
| 14:20 – 15:10 | Update in Treatment of Polymyalgia Rheumatica | Bhaskar Dasgupta |
| 15:10 – 15:40 | ADARRCTM Awards, Recognitions & Closing Remarks | Mustafa Al Maini |
| 15:40 – 16:00 | ADARRCTM Networking & Refreshment Break | |
| Parallel Workshops | ||
| 16:00 – 17:00 | Workshop 1: Periodic Fever Syndromes: More than Autoinflammatory Diseases | Leonardo Oliveira Mendonça |
| 16:00 – 17:00 | Workshop 2: Osteoporosis Treatment after Fracture | Alexandra Papaioannou |
| 16:00 – 17:00 | Workshop 3: Spondyloarthropathy – Juvenile versus Adult Disease | A.V. Ramanan |
| 16:00 – 17:00 | Workshop 4: 2022 ACR/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis | Bhaskar Dasgupta |
| 16:00 – 17:00 | Workshop 5: Management of Patients at Very High Risk of Osteoporotic Fractures through Sequential Treatments | Judith Bubbear |
| END OF DAY 3 | ||
Program as of 16 October 2023.
*Disclaimer: This program is tentative and may be subject to change at the discretion of the Faculty.